59
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Pharmaceutical company developing a new bifunctional peptide growth hormone releasing factor and vasoactive intestinal peptide analog.
About the Company
GRIFFON Pharmaceuticals is a biopharma company located in Montréal, Canada and Lausanne, Switzerland developing a new bifunctional peptide growth hormone releasing factor (GRF) and vasoactive intestinal peptide (VIP) analog. The company aims to develop GP119 in several indications with significant unmet needs. The company’s lead indication, LD-HIV,
is commonly seen in patients with HIV with an approximate prevalence of 200,000 patients in the US.
